Bulletin
Investor Alert

Company Close Updates Archives | Email alerts

Nov. 24, 2020, 4:30 p.m. EST

Moderna Inc. stock falls Tuesday, underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA slipped 2.44% to $98.56 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.31% to 12,036.79 and the Dow Jones Industrial Average DJIA rising 1.54% to 30,046.24. The stock's fall snapped a three-day winning streak. Moderna Inc. closed $4.64 short of its 52-week high ($103.20), which the company achieved on November 16th.

The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV rose 1.74% to $103.96, Amgen Inc. AMGN fell 0.79% to $220.46, and AstraZeneca PLC ADR AZN fell 2.07% to $53.57. Trading volume (12.4 M) eclipsed its 50-day average volume of 10.4 M.

Editor's Note: This story was auto-generated by Automated Insights using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.